NCT05815420 (HOV-C) is a clinical trial of Non invasive ventilation in Chronic Obstructive Pulmonary Disease, sponsored by Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche.

What drugs are being tested in NCT05815420?

Interventions in NCT05815420: Non invasive ventilation.

What condition does NCT05815420 study?

NCT05815420 studies Chronic Obstructive Pulmonary Disease.

Is NCT05815420 still recruiting?

NCT05815420 is currently status unknown. Last updated 20 July 2023.

Last reviewed 2023-07-20 · How we verify

NCT05815420: HOV-C

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home Tele-Monitoring of Non-Invasive Ventilation in COPD Patients in France

Status unknown Last updated 20 July 2023

What this trial tests

trial testing Non invasive ventilation in Chronic Obstructive Pulmonary Disease in 40 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
30 December 2024

30 December 2025

Quick facts

Lead sponsor	Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 September 2023
Primary completion	30 December 2024
Estimated completion	30 December 2025

Drugs / interventions tested

Non invasive ventilation

Conditions studied

Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →

Sponsor

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

Who can join

Adults 18 to 75, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tele-monitoring emerged and unfolded differently among various healthcare organisations and countries. Evidence regarding its impact on the management of COPD patients is still insufficient to draw firm conclusions. Assumption has been made that remote monitoring of home NIV treatment could help to identify novel predictors of the early detection of NIV failure and deteriorations in patients with COPD. The incidence in routine clinical care of unplanned all-cause and COPD-caused hospitalisations in patients treated with NIV therapy who are continuously monitored by telemetric data in France needs evaluation. In addition, predictors of unplanned all-cause and COPD-caused hospitalisations as well as of compliance and persistence to NIV therapy should be assessed in this patient population with special respect to continuous tele-monitoring. The study will determine in France the incidence in routine clinical care of unplanned all-cause and COPD-caused hospitalisations in patients treated with NIV therapy who are continuously monitored by telemetric data. Clinical and telemetric predictors of unplanned all-cause and COPD-caused hospitalisations and of NIV therapy compliance and persistence will be assessed in those patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non invasive ventilation

Trials testing the same drug.

NCT06249009 — Diaphragmatic Work During HFNC and CPAP Support · NA · unknown
NCT05686850 — Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units · NA · recruiting
NCT04971213 — HIgh Flow Versus NIV for Acute Cardiogenic PuLmonary Oedema With Acute Respiratory Failure in an ED · NA · completed
NCT04414891 — Non Invasive Ventilation With NAVA vs ASV for AECOPD · NA · completed
NCT03371628 — Electrical Impedance Tomography in Evaluating the Effects of Noninvasive Ventilation in Post-Operative Cardiac Surgery · NA · unknown

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting

Other Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche trials

Trials by the same sponsor.

NCT04010253 — Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patie · NA · completed
NCT03395418 — Evaluation of the Right Use of Inhaled Therapeutics · completed
NCT03053011 — Evaluation of the Awakening Capability by a Vibrating Bracelet (BRASSARD) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05815420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Last refreshed: 20 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing